
zzso of the prostate is the most common type of cancer, excluding skin cancer, and the second leading cause of cancer death in adult men in the United zzso The lifetime risk for developing symptomatic prostate cancer is one in five for an American zzso A pivotal step in zzso is a shift in the balance between zzso zzso and zzso that favors cell zzso zzso growth zzso zzso is a key negative growth regulator in the normal zzso Although zzso zzso the proliferation of normal prostate cells and functions as a tumor zzso in early zzso it acts as a tumor promoter in later stages of tumor zzso zzso expression of zzso in prostate cancer cells is associated with poor clinical zzso zzso of zzso aids zzso by not only stimulating zzso and suppressing the immune system, but also by acting directly on the prostate tumor zzso While prostate cancer cells become resistant to zzso growth zzso and zzso they retain other zzso responses that enhance zzso such as induction of zzso zzso zzso cell zzso proteins and zzso These direct tumor effects are zzso primarily through zzso zzso This review addresses the mechanisms by which prostate cancer cells may acquire zzso resistance and promote zzso zzso the mechanisms underlying zzso resistance is important for the identification and development of better diagnostic markers and more effective strategies for treating prostate zzso 

